Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Teva
Moodys
Covington
Argus Health
Chinese Patent Office
Daiichi Sankyo
McKesson
Baxter
Federal Trade Commission

Generated: October 20, 2017

DrugPatentWatch Database Preview

Oxtriphylline - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for oxtriphylline and what is the scope of oxtriphylline freedom to operate?

Oxtriphylline
is the generic ingredient in four branded drugs marketed by Watson Labs, Morton Grove, Warner Chilcott Llc, and Parke Davis, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for oxtriphylline.

Summary for Generic Name: oxtriphylline

US Patents:0
Tradenames:4
Applicants:4
NDAs:7
Drug Master File Entries: see list3
Bulk Api Vendors: see list9
Patent Applications: see list2,263
Therapeutic Class:Respiratory Tract Agents
Drug Prices:see low prices
DailyMed Link:oxtriphylline at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis
CHOLEDYL
oxtriphylline
SOLUTION;ORAL009268-012Nov 27, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
CHOLEDYL
oxtriphylline
TABLET, DELAYED RELEASE;ORAL009268-007Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
OXTRIPHYLLINE
oxtriphylline
TABLET, DELAYED RELEASE;ORAL087835-001Aug 25, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Morton Grove
OXTRIPHYLLINE
oxtriphylline
SOLUTION;ORAL088243-001Dec 5, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
CHOLEDYL
oxtriphylline
TABLET, DELAYED RELEASE;ORAL009268-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Warner Chilcott Llc
CHOLEDYL SA
oxtriphylline
TABLET, EXTENDED RELEASE;ORAL087863-001May 24, 1983RXNoYes► Subscribe► Subscribe► Subscribe
Warner Chilcott Llc
CHOLEDYL SA
oxtriphylline
TABLET, EXTENDED RELEASE;ORAL086742-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
CHOLEDYL
oxtriphylline
SYRUP;ORAL009268-011Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Morton Grove
OXTRIPHYLLINE PEDIATRIC
oxtriphylline
SYRUP;ORAL088242-001Dec 5, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
OXTRIPHYLLINE
oxtriphylline
TABLET, DELAYED RELEASE;ORAL087866-001Aug 25, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Cantor Fitzgerald
Accenture
Chinese Patent Office
Johnson and Johnson
Baxter
QuintilesIMS
Fuji
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot